Congratulations to MicroSigX and CUHK on a breakthrough moment — launching MSX Metagenie® ASD risk for children.
Congratulations to MicroSigX and CUHK on a breakthrough moment – launching MSX MetaGenie® ASD risk prediction test for children.
As pioneers in microbiome science, G-NiiB GenieBiome is proud to see this milestone achieved by our ecosystem partners. MSX Metagenie®, the world’s first AI-powered multikingdom microbiome test, backed by FDA Breakthrough Device Designation, represents a major step forward in early neurodevelopmental care.
This innovation not only brings clarity to families but also optimizes healthcare resources — a mission we deeply share. We are especially proud that MicroSigX will start a pilot donation program in January 2026, providing 200 free tests to preschool children in need in Hong Kong. Together, we are shaping a future where microbiome science drives better health outcomes across multiple dimensions.
Congratulations to Prof. Chan, Prof. Ng, MicroSigX and CUHK Medicine!
Learn more about this breakthrough:
CUHK Press Release: https://lnkd.in/gNE92HGp
MicroSigX: www.microsigx.com
#GniiB #MicroSigX #MSXMetagenie #MicrobiomeInnovation #ASD #HealthcareImpact #ScienceForBetterLives #創新 #自閉症 #醫療影響 #微生物科學
